Bleeding of a familial cerebral cavernous malformation after prophylactic anticoagulation therapy. Case report.

Abstract excerpt

The risk of hemorrhage in cavernous malformations (CMs) depends on lesion, host, and environmental factors. Anticoagulation therapy is a well-known risk factor for intracerebral bleeding, but the occurrence of hemorrhages in patients with CMs has not been reported. Low molecular weight heparin therapy is generally considered to be safe, although significant hemorrhagic complications have recently been reported....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anticoagulants
• Share to Cerebral Hemorrhage